| AJCC | American Joint Committee on Cancer |
| BRAF/MEKi | BRAF/MEK inhibitors |
| CLND | completion lymphadenectomy |
| DMFS | distant-metastases-free survival |
| DT | dabrafenib plus trametinib |
| HR | hazard ratio |
| ICI | immune check point inhibitors |
| NSLN | nonsentinel lymph node metastases |
| OS | overall survival |
| RFS | relapse-free survival |
| SLNB | sentinel lymph node biopsy |
| TLND | therapeutic lymph node dissection |
| TRAE | treatment-related adverse events |
| WHO | World Health Organisation |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.